Outcomes of laparoscopic adrenalectomy for hyperladosteronism

ANZ Journal of Surgery

Volumn 77, Issue 9, 2007, Pages 768-773

  Pang, Tony C ^a   Bambach, Chris ^a   Monaghan, Judith C ^b   Sidhu, Stan B ^a   Bune, Alex ^b   Delbridge, Leigh W ^a   Sywak, Mark S ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c Northern Endocrine and Breast Surgery Centre   (Australia)

Author keywords

Conn's syndrome; Hypertension; Laparoscopic adrenalectomy; Primary hyperladosteronism

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; POTASSIUM; RENIN;

ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN SIZE; PLASMA RENIN ACTIVITY; POSTOPERATIVE PERIOD; POTASSIUM BLOOD LEVEL; PREOPERATIVE EVALUATION; PRIMARY HYPERALDOSTERONISM; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADRENAL CORTEX DISEASES; ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; HYPERTENSION; LAPAROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34547652134     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04225.x     Document Type: Article

References (37)

1. Hansson L, Zanchetti A, Carruthers S et al. Effects of intensive blood-pressure lowering and low-dose aspirin on patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group. Lancet 1998 351 : 1755 62.
2. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002 40 : 892 6.
3. Fardella CE, Mosso L, Gomez-Sanchez C et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J. Clin. Endocrinol. Metab. 2000 85 : 1863 7.
4. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J. Hum. Hypertens. 2000 14 : 311 15.
5. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999 353 : 40.
6. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 2000 85 : 2854 9.
7. Stowasser M, Gordon RD, Gunasekera TG et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J. Hypertens. 2003 21 : 2149 57.
8. Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J. Hum. Hypertens. 2003 17 : 349 52.
9. Wheeler MH, Harris DA. Diagnosis and management of primary aldosteronism. World J. Surg. 2003 27 : 627 31.
10. Young WF Jr. Primary aldosteronism: a common and curable form of hypertension. Cardiol. Rev. 1999 7 : 207 14.
11. Rizzoni D, Porteri E, Castellano M et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996 28 : 785 90.
12. Rossi GP, Sacchetto A, Pavan E et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997 95 : 1471 8.
13. Shigematsu Y, Hamada M, Okayama H et al. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997 29 : 723 7.
14. Tanabe A, Naruse M, Naruse K et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens. Res. 1997 20 : 85 90.
15. Rubinstein M, Gill IS, Aron M et al. Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy. J. Urol. 2005 174 : 442 5 discussion 445.
16. Sechi LA, Novello M, Lapenna R et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006 295 : 2638 45.
17. Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003 144 : 2208 13.
18. Young WF Jr. Primary aldosteronism - treatment options. Growth Horm. IGF Res. 2003 13 (Suppl. A S102 8.
19. Celen O, O'Brien MJ, Melby JC et al. Factors influencing outcome of surgery for primary aldosteronism. Arch. Surg. 1996 131 : 646 50.
20. Meria P, Kempf BF, Hermieu JF et al. Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J. Urol. 2003 169 : 32 5.
21. Rossi H, Kim A, Prinz RA. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am. Surg. 2002 68 : 253 6 discussion 256-7.
22. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br. J. Surg. 2002 89 : 1587 93.
23. Ishidoya S, Ito A, Sakai K et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J. Urol. 2005 174 : 40 43.
24. Goh BK, Tan YH, Yip SK, Eng PH, Cheng CW. Outcome of patients undergoing laparoscopic adrenalectomy for primary hyperaldosteronism. JSLS 2004 8 : 320 25.
25. Harris DA, Au-Yong I, Basnyat PS, Sadler GP, Wheeler MH. Review of surgical management of aldosterone secreting tumours of the adrenal cortex. Eur. J. Surg. Oncol. 2003 29 : 467 74.
26. Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenalectomy for primary aldosteronism. World J. Surg. 2005 29 : 155 9.
27. Lo CY, Tam PC, Kung AW, Lam KS, Wong J. Primary aldosteronism. Results of surgical treatment. Ann. Surg. 1996 224 : 125 30.
28. Sawka AM, Young WF, Thompson GB et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann. Intern. Med. 2001 135 : 258 61.
29. Fukudome Y, Fujii K, Arima H, Ohya Y, Tsuchihashi T, Abe I, Fujishima M. Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens. Res. 2002 25 : 11 18.
30. Zeh HJ 3rd., Udelsman R. One hundred laparoscopic adrenalectomies: a single surgeon's experience. Ann. Surg. Oncol. 2003 10 : 1012 17.
31. Assalia A, Gagner M. Laparoscopic adrenalectomy. Br. J. Surg. 2004 91 : 1259 74.
32. Mutoh M, Takeyama K, Nishiyama N et al. Systemic inflammatory response syndrome in open versus laparoscopic adrenalectomy. Urology 2004 64 : 422 5.
33. Poulin EC, Schlachta CM, Burpee SE, Pace KT, Mamazza J. Laparoscopic adrenalectomy: pathologic features determine outcome. Can. J. Surg. 2003 46 : 340 44.
34. Kim AW, Quiros RM, Maxhimer JB, El-Ganzouri AR, Prinz RA. Outcome of laparoscopic adrenalectomy for pheochromocytomas vs aldosteronomas. Arch. Surg. 2004 139 : 526 9 discussion 529 31.
35. Gockel I, Heintz A, Kentner R, Werner C, Junginger T. Changing pattern of the intraoperative blood pressure during endoscopic adrenalectomy in patients with Conn's syndrome. Surg. Endosc. 2005 19 : 1491 7.
36. O'Boyle CJ, Kapadia CR, Sedman PC, Brough WA, Royston CM. Laparoscopic transperitoneal adrenalectomy. Surg. Endosc. 2003 17 : 1905 9.
37. Conn JW. Primary aldosteronism. J. Lab. Clin. Med. 1955 45 : 661 4.